Menu

 

MAC_LOGO_Transparent_background    EP_Logo_Transparent

 

 

MEPs Against Cancer (MAC), a European Parliament Interest Group  

 

 

Peterle 002

 For use

 

 

 

 

 

 

  

MAC members of the of the Eighth Legislature 2014-2019:

Alojz Peterle, MAC President (EPP, Slovenia), Nessa Childers MAC Vice President (S&D, Ireland) Pavel Poc, MAC Vice President  (S&D, Czech Republic) Charles Tannock MAC Vice President (ECR, UK), Ivo Belet (EPP, Belgium) Lynn Boylan (GUE/NGL, Ireland) Biljana Brozan (S&D, Croatia), Christian Buşoi (EPP, Romania), Matt Carthy (GUE/NGL, Ireland), Deirdre Clune (EPP, Ireland) Lorenzo Fontana (NI, Italy), Françoise Grossetête, (EPP, France), Marian Harkin (ALDE, Ireland), Brian Hayes (EPP, Ireland), Anneli Jäätteenmäki (ALDE, Finland), Sean Kelly (EPP, Ireland), Mr Miroslav Mikolášik (EPP, Slovakia), Sirpa Pietikäinen (EPP, Finland), Michèle Rivasi (Greens/EFA, France), Christel Schaldemose (S&D, Denmark) Glenis Willmott (S&D, UK)

 

 "I think it is crucial for this term to provide more added value in the fight against cancer at the EU level, as well as better co-operation with stakeholders in the Member States. What is of the utmost importance is a concrete preventive policy in order to diminish the inflow of new cancer patients, which has been also the wish of the cancer patients in the EU."

- Mr Alojz Peterle, MAC President

 

The MEPs Against Cancer (MAC) group is an informal group of Members of the European Parliament (MEPs) at the European Parliament committed to actions against cancer. The MEPs Against Cancer work together in order to improve cancer prevention and control in Europe, in the belief that European cooperation adds value to member state actions. In order to address the challenges faced by the EU, MAC works together with the European Commission and Council and collaborate with relevant organisations to reduce cancer incidence by 15% by the year 2020.

In the 2014 to 2019 legislature the strategic goal of the MEPs Against Cancer (MAC) group is to reduce cancer incidence by:

  • promoting prevention,
  • reducing mortality by ensuring equitable access to high quality treatment and care, and
  • ensuring a good quality of life for cancer patients and survivors.

 

The Association of European Cancer Leagues (ECL) is proud to provide the Secretariat for MAC. For more information or to become a MAC member, please contact us at This email address is being protected from spambots. You need JavaScript enabled to view it.

 

Interact with us

Like us on Facebook 

Follow us on Twitter 

See us on Flickr

 

News

"MEPs unite in the fight against Cancer", Parliament Magazine, January 2015

MAC Press Release on the 4th Revision of the European Code against Cancer, October 2014

Check our events page for past and future meetings

 

 

Why we do what we do: The facts speak for themselves

Cancer is not one disease but over 200 different  types of disease, ranging from the well-known big cancer killers to rarer conditions

In 2012, there was an estimated 3.4 million new cases (excluding non-melanoma skin), and 1.8 million cancer deaths in Europe.

Both genders were affected almost equally: of the 3,439,598 new cancer cases diagnosed in 2012, 53.2% were among men and 46.8% among women.

There were 1,754,550 cancer deaths, of which 55.9% were in men and 44.1% in women. The biggest killers of the 1.8 million deaths in 2012 were lung, colorectal, breast, and stomach cancers.

Although cancer survivorship figures have increased, survival rates differ vastly across Europe. Countries with lowest survival for most cancers (Bulgaria, Estonia, Latvia, Lithuania, Poland, and Slovakia) are in Eastern Europe. Here, survival is below the European mean, particularly for good prognosis cancers like colon, rectum, lymphomas, and skin melanoma.  Nordic countries (with the exception of Denmark), central European countries such as Austria, Belgium, France, Germany, Switzerland, and Netherlands, and some countries in southern Europe (Italy, Portugal, and Spain), have the best survival for most cancers.

Childhood cancer remains a public health issue. Survival at 5 years from diagnosis for children (0-14 years) for all cancers combined is generally good, with 79% now surviving (2005–2007), up from 76% in 1999–2001. 

You may be interested...

European Week Against Cancer!

       EUROPEAN WEEK AGAINST CANCER IS 25-31 MAY EACH YEAR  2015 Events [ ... ]

+ Full Story
Cancer Control Policy Conference on Survivorship: ...

  PRESS RELEASE Embargoed until 12 noon 13 May 2015, Brussels   Survivorship in canc [ ... ]

+ Full Story
European Week against Cancer Youth Workshop, Brno,...

   Youth Workshop on Disseminating the European Code against Cancer -  Gathering Y [ ... ]

+ Full Story
First Policy Conference of the Cancer Control Join...

                   & [ ... ]

+ Full Story
Other Articles

Translate (done by a generic software and translations will be flawed)

English French German Italian Portuguese Russian Spanish
 
 

   

logo_EWAC_transparent_background_w_DATES     cancon logo horizontal RGB SMALL    rarecancers_logo_tagline_rgb_72dpi

 

The text of this webpage is available for modification and reuse under the terms of the Creative Commons Attribution-Sharealike 3.0 Unported License and the GNU Free Documentation License (unversioned, with no invariant sections, front-cover texts, or back-cover texts).

 

 
Go to top